Mantle Cell Lymphoma
Recent Results Show ibrutinib-Based Combination Regimen Significantly Reduced the Risk of Disease Progression or Death in Older Patients with Newly Diagnosed Mantle Cell Lymphoma The Janssen Pharmaceutical Company today announced primary results from the Phase 3 SHINE study, which demonstrated that the combination of once-daily oral ibrutinib plus bendamustine-rituximab (BR) and rituximab maintenance significantly […]
Hepatocellular carcinoma
Hepatocellular carcinoma (HCC) Liver cancer is a global health challenge, with an estimated incidence of >1 million patients by 2025. Primary liver cancer is one that started in the liver. There are 5 main types. The type of liver cancer depends on the cell type that the cancer started in. If cancer began somewhere else […]
Tyrosine kinase Inhibitors for Acute lymphocytic leukemia
Tyrosine kinase inhibitors for acute lymphocytic leukemia (ALL) What is acute lymphocytic leukemia (ALL)? Acute lymphocytic leukemia which is called ALL, is an aggressive form of leukemia, in which too many lymphoblasts or lymphocytes are presented in the peripheral blood and bone marrow. In acute lymphocytic leukemia (ALL), cancer can spread to other part of […]
Chronic Myeloid Leukemia (CML)
A quick overview over chronic myeloid leukemia (CML) Chronic myeloid leukemia (CML) is an uncommon form of the bone marrow cancer. In CML we can see an increased number of white blood cells (WBC) in the blood. Too many blood stem cells become a type of WBC which is called granulocytes. They aren’t healthy white blood cells and are […]
Chronic lymphocytic leukemia (CLL)
Quick review over chronic lymphocytic leukemia (CLL) Chronic lymphocytic leukemia which is also called CLL is a cancer of the blood and bone marrow which usually is worsen slowly; many patients don’t have any symptoms for at least the first few years, but over time, the cancer grows and spreads to other parts of the body, including the liver, spleen, and lymph […]
Small Lymphocytic Lymphoma SLL
Small Lymphocytic Lymphoma (SLL) overview: Chronic lymphocytic leukemia (CLL) and Small Lymphocytic Lymphoma (SLL) are cancers of the immune system; which affect lymphocytes. CLL and SLL are basically the same, the only difference is each cancer is primarily located in a different part of the body. When cancer occurs in bloodstream and the bone […]
Mantle cell lymphoma (MCL)
Quick overview of Mantle cell lymphoma (MCL) Mantle cell lymphoma (MCL) is grouped as one of the rare B-cell non-Hodgkin lymphoma (NHL). In non-Hodgkin lymphoma cancer, the lymphatic system is affected. About 6 to 8 percent of all NHLs are Mantle cell lymphoma (MCL). This type of cancer is called “mantle cell lymphoma”, because […]
Marginal Zone Lymphoma (MZL)
Quick overview of Marginal Zone Lymphoma (MZL): Marginal zone lymphoma (MZL) which is also called marginal zone B-cell lymphoma, is a group of B-cell non-Hodgkin lymphomas, which at first is formed in certain areas (the marginal zones) of lymph tissue. MZL is the second most common indolent non-Hodgkin’s lymphoma (iNHL); and account for approximately eight […]
Waldenstrom Macroglobulinemia (WM)
Introduction of Waldenstrom Macroglobulinemia (WM) Waldenstrom Macroglobulinemia (WM) is a non-Hodgkin lymphoma (NHL), in which the cancer cells make large amounts of an abnormal protein (called a macroglobulin). Another name for this subtype of NHL cancers is lymphoplasmacytic lymphoma. This condition is a rare indolent B-cell lymphoma that occurs in less than two percent of […]
Graft-versus-Host Disease (GvHD)
Quick Review over Graft-versus-Host Disease (GvHD) Introduction: Graft-versus-Host Disease (GvHD) is a common complication because of a transplantation using donor; this complication occurs when the donor’s immune system (the graft) recognizes the patient’s organs and tissues (the host) as unfamiliar cells that should be destroyed. This complication is triggered by a type of white blood cell […]